These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10698464)

  • 1. Comparative study of the pharmacokinetic characteristics of slow release theophylline oral preparations in Thai children with persistent asthma.
    Trakultivakorn M; Kanthawatana S; Tontayapiwat A; Jiraporncharoen K
    Asian Pac J Allergy Immunol; 1999 Dec; 17(4):255-9. PubMed ID: 10698464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-dose comparison of three slow-release theophylline oral preparations in healthy Thai volunteers.
    Kanthawatana S; Tontayapiwat A; Tonsuwannont W; Manorot M
    Asian Pac J Allergy Immunol; 1996 Jun; 14(1):13-8. PubMed ID: 8980795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline pharmacokinetics in Thai children.
    Vichyanond P; Aranyanark N; Visitsuntorn N; Tuchinda M
    Asian Pac J Allergy Immunol; 1994 Dec; 12(2):137-43. PubMed ID: 7612107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of a generic slow-release theophylline tablet in children.
    Kanthawatana S; Ahrens RC; McCubbin M; Bronsky E; Blake K; Hendeles L
    J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of steady-state serum theophylline concentration in children by first-order and zero-order absorption models.
    Kato Z; Fukutomi O; Yamazaki M; Kondo N; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 May; 32(5):231-4. PubMed ID: 7921516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ; Wiener MB; Hill MR; Szefler SJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB
    Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic equivalence of a generic slow-release theophylline tablet.
    Hendeles L; Breton AL; Beaty R; Harman E
    Pharmacotherapy; 1995; 15(1):26-35. PubMed ID: 7739942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
    Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
    J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Theolair SR and Theo-Dur tablets.
    Domson JF; Hein EW; Sheen A; Sly RM
    Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oral theophylline in Thai asthmatic children.
    Koysooko R; Tuchinda M; Habananada S; Pinthong T; Wattanapermpool J; Geadsomnuig S
    Asian Pac J Allergy Immunol; 1987 Dec; 5(2):179-85. PubMed ID: 3449080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent inconsistent theophylline absorption from sustained release capsules.
    Uden DL; Schaber DE; Wyatt RA
    Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
    Plusa T; Józefczak E; Raczka A
    Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.